The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Type I interferon: friend or foe?
Open accessAbstract
Although the role of type I interferon (IFN) in the protection against viral infections has been known and studied for decades, its role in other immunologically relevant scenarios, including bacterial infections, shock, autoimmunity, and cancer, is less well defined and potentially much more complicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citationRNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
Chiu, Y.-H., MacMillan, J. B., & Chen, Z. J. (2009) · Cell · doi:10.1016/j.cell.2009.06.015 · Cited by 1,174
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Marie, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Brière, F., et al. (2001) · Nature Immunology · doi:10.1038/ni736 · Cited by 1,022
Self-citationSpecificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.-C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., et al. (2006) · Nature · doi:10.1038/nature04369 · Cited by 968
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A., & Cheng, G. (2006) · Nature · doi:10.1038/nature04374 · Cited by 881
A protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
Viral evasion and subversion of pattern-recognition receptor signalling
Bowie, A. G., & Unterholzner, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2436 · Cited by 746
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., & Gilliet, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 740
Trinchieri, G., & Santoli, D. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1314 · Cited by 733
Self-citationThe AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Fernandes-Alnemri, T., Yu, J.-W., Juliana, C., Solorzano, L., Kang, S., Wu, J., Datta, P., McCormick, M., Huang, L., McDermott, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1859 · Cited by 732
The interferon response circuit: Induction and suppression by pathogenic viruses
Haller, O., Kochs, G., & Weber, F. (2006) · Virology · doi:10.1016/j.virol.2005.09.024 · Cited by 681
A critical function for type I interferons in cancer immunoediting
Dunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M., et al. (2005) · Nature Immunology · doi:10.1038/ni1213 · Cited by 605
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Manca, C., Tsenova, L., Bergtold, A., Freeman, S., Tovey, M., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 595
IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells
Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., & Roncarolo, M.-G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5530 · Cited by 595
Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E. M., Trinchieri, G., Caux, C., & Garrone, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041964 · Cited by 537
Self-citationComplex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.
Brinkmann, V, Geiger, T., Alkan, S., & Heusser, C. H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1655 · Cited by 506
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
O'Connell, R. M., Saha, S. K., Vaidya, S. A., Bruhn, K. W., Miranda, G. A., Zarnegar, B., Perry, A. K., Nguyen, B. O., Lane, T. F., Taniguchi, T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040712 · Cited by 489
A weak signal for strong responses: interferon-alpha/beta revisited
Taniguchi, T., & Takaoka, A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073080 · Cited by 483
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2527 · Cited by 480
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice
Shahangian, A., Chow, E. K., Tian, X., Kang, J. R., Ghaffari, A., Liu, S. Y., Belperio, J. A., Cheng, G., & Deng, J. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35412 · Cited by 479
The Yin and Yang of type I interferon activity in bacterial infection
Decker, T., Müller, M., & Stockinger, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1684 · Cited by 468
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes
Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M., & Portnoy, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040976 · Cited by 450
Lin, K. L., Suzuki, Y., Nakano, H., Ramsburg, E., & Gunn, M. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2562 · Cited by 442
Besch, R., Poeck, H., Hohenauer, T., Senft, D., Häcker, G., Berking, C., Hornung, V., Endres, S., Ruzicka, T., Rothenfusser, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37155 · Cited by 433
Stanley, S. A., Johndrow, J. E., Manzanillo, P., & Cox, J. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3143 · Cited by 432
Yarilina, A., Park-Min, K.-H., Antoniv, T., Hu, X., & Ivashkiv, L. B. (2008) · Nature Immunology · doi:10.1038/ni1576 · Cited by 429
Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection
Carrero, J. A., Calderon, B., & Unanue, E. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040769 · Cited by 390
Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K.-P., Hanisch, U.-K., Raasch, J., Merkler, D., Detje, C., Gutcher, I., Mages, J., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.011 · Cited by 387
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T., Punaro, M., Bolland, S., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Guo, B., Chang, E. Y., & Cheng, G. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33342 · Cited by 371
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshäuser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., et al. (2003) · Nature Immunology · doi:10.1038/ni910 · Cited by 361
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells
Mancuso, G., Gambuzza, M., Midiri, A., Biondo, C., Papasergi, S., Akira, S., Teti, G., & Beninati, C. (2009) · Nature Immunology · doi:10.1038/ni.1733 · Cited by 351
Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function
Swann, J. B., Hayakawa, Y., Zerafa, N., Sheehan, K. C. F., Scott, B., Schreiber, R. D., Hertzog, P., & Smyth, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7540 · Cited by 339
Cross Talk Between Interferon-γ and -α/β Signaling Components in Caveolar Membrane Domains
Takaoka, A., Mitani, Y., Suemori, H., Sato, M., Yokochi, T., Noguchi, S., Tanaka, N., & Taniguchi, T. (2000) · Science · doi:10.1126/science.288.5475.2357 · Cited by 319
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303
Trinchieri, G., Santoli, D., Dee, R. R., & Knowles, B. B. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.5.1299 · Cited by 299
Self-citationMcWhirter, S. M., Barbalat, R., Monroe, K. M., Fontana, M. F., Hyodo, M., Joncker, N. T., Ishii, K. J., Akira, S., Colonna, M., Chen, Z. J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082874 · Cited by 296
Manca, C., Tsenova, L., Freeman, S., Barczak, A. K., Tovey, M., Murray, P. J., Barry, C., & Kaplan, G. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.694 · Cited by 294
Antonelli, L. R. V., Gigliotti Rothfuchs, A., Gonçalves, R., Roffê, E., Cheever, A. W., Bafica, A., Salazar, A. M., Feng, C. G., & Sher, A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40817 · Cited by 292
Pandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M. A., Fitzgerald, K. A., Sassetti, C. M., & Kelliher, M. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000500 · Cited by 292
Denny, M. F., Thacker, S., Mehta, H., Somers, E. C., Dodick, T., Barrat, F. J., McCune, W. J., & Kaplan, M. J. (2007) · Blood · doi:10.1182/blood-2007-05-089086 · Cited by 282
Interferon-α and cancer: Mechanisms of action and new perspectives of clinical use
Ferrantini, M., Capone, I., & Belardelli, F. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.006 · Cited by 268
Watanabe, T., Asano, N., Fichtner-Feigl, S., Gorelick, P. L., Tsuji, Y., Matsumoto, Y., Chiba, T., Fuss, I. J., Kitani, A., & Strober, W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39481 · Cited by 262
IL-28 and IL-29: Newcomers to the interferon family
Uzé, G., & Monneron, D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.008 · Cited by 260
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Mancuso, G., Midiri, A., Biondo, C., Beninati, C., Zummo, S., Galbo, R., Tomasello, F., Gambuzza, M., Macrì, G., Ruggeri, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3126 · Cited by 251
Ling, P. D., Warren, M. K., & Vogel, S. N. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.1857 · Cited by 209
Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ
Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K., & Lenz, L. L. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091746 · Cited by 208
Wenzel, J., & Tüting, T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.96 · Cited by 203
Li, X., Leung, S., Qureshi, S., Darnell, J. E., & Stark, G. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5790 · Cited by 198
Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
Gough, D. J., Messina, N. L., Hii, L., Gould, J. A., Sabapathy, K., Robertson, A. P. S., Trapani, J. A., Levy, D. E., Hertzog, P. J., Clarke, C. J. P., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000361 · Cited by 193
Li, X., Leung, S., Kerr, I. M., & Stark, G. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2048 · Cited by 185
Tailor, P., Tamura, T., Kong, H. J., Kubota, T., Kubota, M., Borghi, P., Gabriele, L., & Ozato, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.009 · Cited by 180
Toll‐like receptors’ two‐edged sword: when immunity meets apoptosis
Salaun, B., Romero, P., & Lebecque, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200737744 · Cited by 179
Antiproliferative Properties of Type I and Type II Interferon
Bekisz, J., Baron, S., Balinsky, C. A., Morrow, A., & Zoon, K. C. (2010) · Pharmaceuticals · doi:10.3390/ph3040994 · Cited by 166
Fehr, T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M., Bachmann, M. F., Mak, T. W., Horak, I., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.921 · Cited by 162
Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial Infections
Henry, T., Kirimanjeswara, G. S., Ruby, T., Jones, J. W., Peng, K., Perret, M., Ho, L., Sauer, J.-D., Iwakura, Y., Metzger, D. W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902065 · Cited by 162
Systemic lupus erythematosus and the type I interferon system.
Rönnblom, L., & Alm, G. V. (2003) · Arthritis Research · doi:10.1186/ar625 · Cited by 158
Triantafyllopoulou, A., Franzke, C.-W., Seshan, S. V., Perino, G., Kalliolias, G. D., Ramanujam, M., van Rooijen, N., Davidson, A., & Ivashkiv, L. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914902107 · Cited by 156
A Genomic Approach to Human Autoimmune Diseases
Pascual, V., Chaussabel, D., & Banchereau, J. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101221 · Cited by 152
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses
Navarini, A. A., Recher, M., Lang, K. S., Georgiev, P., Meury, S., Bergthaler, A., Flatz, L., Bille, J., Landmann, R., Odermatt, B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607325103 · Cited by 144
Genetics of SLE: evidence from mouse models
Morel, L. M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.63 · Cited by 144
Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S., & Orme, I. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6879-6882.2000 · Cited by 135
Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes
Carrero, J. A., Calderón, B., & Unanue, E. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060045 · Cited by 135
Kelly‐Scumpia, K. M., Scumpia, P. O., Delano, M. J., Weinstein, J. S., Cuenca, A. G., Wynn, J. L., & Moldawer, L. L. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091959 · Cited by 132
Agrawal, H., Jacob, N., Carreras, E., Bajaña, S., Putterman, C., Turner, S., Neas, B. R., Mathian, A., Koss, M. N., Stohl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803872 · Cited by 130
Boasso, A., Hardy, A. W., Anderson, S. A., Dolan, M. J., & Shearer, G. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002961 · Cited by 128
Qiu, H., Fan, Y., Joyee, A. G., Wang, S., Han, X., Bai, H., Jiao, L., van Rooijen, N., & Yang, X. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2092 · Cited by 125
Freudenberg, M. A., Merlin, T., Kalis, C., Chvatchko, Y., STÜBIG, H., & Galanos, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1665 · Cited by 121
Malik, U. R., Makower, D., & Wadler, S. (2001) · Cancer · Cited by 118
Young, H. A., & Bream, J. H. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_6 · Cited by 115
Choubey, D., Duan, X., Dickerson, E., Ponomareva, L. V., Panchanathan, R., Shen, H., & Srivastava, R. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0096 · Cited by 114
Rönnblom, L., Alm, G. V., & Eloranta, M. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832e089e · Cited by 111
Rizza, P., Moretti, F., & Belardelli, F. (2010) · Autoimmunity · doi:10.3109/08916930903510880 · Cited by 108
Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity
Byrnes, A. A., Ma, X., Cuomo, P. J., Park, K., Wahl, L. M., Wolf, S. F., Zhou, H., Trinchieri, G., & Karp, C. L. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200107)31:7<2026::aid-immu2026>3.0.co;2-u · Cited by 102
Self-citationGuiducci, C., Coffman, R. L., & Barrat, F. J. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02050.x · Cited by 99
Zhai, Y., Qiao, B., GAO, F. G., Shen, X., Vardanian, A. J., Busuttil, R. W., & Kupiec‐Weglinski, J. W. (2007) · Hepatology · doi:10.1002/hep.21970 · Cited by 97
Miller, J. C., Ma, Y., Bian, J., Sheehan, K. C. F., Zachary, J. F., Weis, J. H., Schreiber, R. D., & Weis, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8492 · Cited by 94
Dikopoulos, N., Bertoletti, A., Kröger, A., Häuser, H., Schirmbeck, R., & Reimann, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.99 · Cited by 87
Interferons Direct an Effective Innate Response to Legionella pneumophila Infection
Plumlee, C. R., Lee, C., Beg, A. A., Decker, T., Shuman, H. A., & Schindler, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018283 · Cited by 86
Type I interferon drives tumor necrosis factor–induced lethal shock
Huys, L., Hauwermeiren, F. V., Dejager, L., Dejonckheere, E., Lienenklaus, S., Weiß, S., Leclercq, G., & Libert, C. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090213 · Cited by 84
On watching the watchers: IDO and type I/II IFN
Puccetti, P. (2007) · European Journal of Immunology · doi:10.1002/eji.200737184 · Cited by 83
Jia, T., Leiner, I. M., Dorothée, G., Brandl, K., & Pamer, E. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900460 · Cited by 80
Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs
Hasan, U. A., Caux, C., Perrot, I., Doffin, A., Ménétrier‐Caux, C., Trinchieri, G., Tommasino, M., & Vlach, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700664104 · Cited by 79
Self-citationHomeostatic Effects of TLR9 Signaling in Experimental Colitis
Lee, J., Rachmilewitz, D., & Raz, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.022 · Cited by 72
Yarilina, A., DiCarlo, E. F., & Ivashkiv, L. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2204 · Cited by 69
Type I IFN Modulates Host Defense and Late Hyperinflammation in Septic Peritonitis
Weighardt, H., Kaiser‐Moore, S., Schlautkötter, S., Roßmann-Bloeck, T., Schleicher, U., Bogdan, C., & Holzmann, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5623 · Cited by 67
Ishihara, T., Aga, M., Hino, K., Ushio, C., Taniguchi, M., Iwaki, K., Ikeda, M., & Kurimoto, M. (2005) · Biomedical Research · doi:10.2220/biomedres.26.179 · Cited by 52
Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity
Prchal‐Murphy, M., Pilz, A., Simma, O., Lingnau, K., von Gabain, A., Strobl, B., Müller, M. M., & Decker, T. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.016 · Cited by 51
de la Maza, L. M., Peterson, E. M., Goebel, J. M., Fennie, C., & Czarniecki, C. W. (1985) · Infection and Immunity · doi:10.1128/iai.47.3.719-722.1985 · Cited by 50
Autoimmunity, infection and adjuvants
Nr, R. (2010) · Lupus · doi:10.1177/0961203309360670 · Cited by 50
Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta
Comı, G. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.06.007 · Cited by 50
Gold, J. A., Hoshino, Y., Hoshino, S., Jones, M. B., Nolan, A., & Weiden, M. D. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1291-1297.2004 · Cited by 49
[Inhibition of vaccinia infection by a liquid factor in tissues infected by homologous virus].
Nagano, Y., & KOJIMA, Y. (1958) · PubMed · Cited by 45
Regulation of immune cell homeostasis by type I interferons
Mattei, F., Schiavoni, G., & Tough, D. F. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.05.002 · Cited by 42
Buß, C., Opitz, B., Hocke, A. C., Lippmann, J., van Laak, V., Hippenstiel, S., Krüll, M., Suttorp, N., & Eitel, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902947 · Cited by 42
Type I IFN are host modulators of strain-specific Listeria monocytogenes virulence
Reutterer, B., Stockinger, S., Pilz, A., Soulat, D., Kastner, R., Westermayer, S., Rülicke, T., Müller, M. M., & Decker, T. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01114.x · Cited by 41
Upregulation of a Small Subset of Genes Drives Type I Interferon-Induced Antiviral Memory
Jaitin, D. A., & Schreiber, G. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0162 · Cited by 37
Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes
Stockinger, S., & Decker, T. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.020 · Cited by 35
Type I interferon therapy and its role in autoimmunity
Biggioggero, M., Gabbriellini, L., & Meroni, P. L. (2010) · Autoimmunity · doi:10.3109/08916930903510971 · Cited by 34
Moschos, S. J., & Kirkwood, J. M. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.020 · Cited by 26
Cited by
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,419
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Type I interferons in anticancer immunity
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J., & Kroemer, G. (2015) · Nature Reviews Immunology · doi:10.1038/nri3845 · Cited by 1,305
Metadata
- Authors
- Trinchieri, G.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-09-13
- Volume
- 207
- Issue
- 10
- Pages
- 2053-2063
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2020173029
- Cited by
- 844
- References
- 109
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.